Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy.

[1]  E. Perucca,et al.  Rufinamide: Clinical pharmacokinetics and concentration–response relationships in patients with epilepsy , 2008, Epilepsia.

[2]  A. Birnbaum,et al.  High-Speed Simultaneous Determination of Nine Antiepileptic Drugs Using Liquid Chromatography-Mass Spectrometry , 2008, Therapeutic drug monitoring.

[3]  T. A. Vermeij,et al.  Robust isocratic high performance liquid chromatographic method for simultaneous determination of seven antiepileptic drugs including lamotrigine, oxcarbazepine and zonisamide in serum after solid-phase extraction. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  M. Krasowski,et al.  Simultaneous determination of lamotrigine, zonisamide, and carbamazepine in human plasma by high-performance liquid chromatography. , 2007, Biomedical chromatography : BMC.

[5]  Xiao-jin Shi,et al.  Isocratic Reversed-Phase HPLC for Simultaneous Separation and Determination of Seven Antiepileptic Drugs and Two of their Active Metabolites in Human Plasma , 2007 .

[6]  Terumitsu Yoshida,et al.  Simultaneous determination of zonisamide, carbamazepine and carbamazepine-10,11-epoxide in infant serum by high-performance liquid chromatography. , 2006, Journal of pharmaceutical and biomedical analysis.

[7]  T. Tomson,et al.  Pharmacokinetic Variability of Newer Antiepileptic Drugs , 2006, Clinical pharmacokinetics.

[8]  G. McMillin,et al.  Drug monitoring and toxicology: a procedure for the monitoring of levetiracetam and zonisamide by HPLC-UV. , 2006, Journal of analytical toxicology.

[9]  M. Contin,et al.  Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  H. Neels,et al.  Therapeutic drug monitoring of old and newer anti-epileptic drugs , 2004, Clinical chemistry and laboratory medicine.

[11]  Y. Katagiri,et al.  High-performance liquid chromatographic assay of zonisamide in human plasma using a non-porous silica column. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[12]  T. Mimaki,et al.  Clinical pharmacology and therapeutic drug monitoring of zonisamide. , 1998, Therapeutic drug monitoring.

[13]  M. Rouan,et al.  Automated analysis of a novel anti-epileptic compound, CGP 33,101, and its metabolite, CGP 47,292, in body fluids by high-performance liquid chromatography and liquid-solid extraction. , 1995, Journal of chromatography. B, Biomedical applications.

[14]  R. Oishi,et al.  Simple and sensitive assay of zonisamide in human serum by high-performance liquid chromatography using a solid-phase extraction technique. , 1994, Journal of chromatography. B, Biomedical applications.

[15]  L. A. Brunner,et al.  An automated method for the determination of a new potential antiepileptic agent (CGP 33101) in human plasma using high performance liquid chromatography. , 1992, Biomedical chromatography : BMC.

[16]  D. Berry.  Determination of zonisamide (3-sulphamoylmethyl-1,2-benzisoxazole) in plasma at therapeutic concentrations by high-performance liquid chromatography. , 1990, Journal of chromatography.